Pulmonary delivery of inhibitors of phosphodiesterase type 5

Details for Australian Patent Application No. 2005277042 (hide)

Owner MannKind Corporation

Inventors Grant, Marshall; Leone-Bay, Andrea; Diamond, David C.; Fog, Per B.; Cheatham, Wayman Wendell

Agent Spruson & Ferguson

Pub. Number AU-A-2005277042

PCT Pub. Number WO2006/023944

Priority 60/603,764 23.08.04 US

Filing date 23 August 2005

Wipo publication date 2 March 2006

International Classifications

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/023944 Priority application(s): WO2006/023944

23 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005277050-Hydraulic set permanent packer with isolation of hydraulic actuator and built in redundancy

2005277041-Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery